A review of Bruton’s tyrosine kinase inhibitors in multiple sclerosis
Bruton’s tyrosine kinase (BTK) inhibitors are an emerging class of therapeutics in multiple sclerosis (MS). BTK is expressed in B-cells and myeloid cells, key progenitors of which include dendritic cells, microglia and macrophages, integral effectors of MS pathogenesis, along with mast cells, establ...
Na minha lista:
| Principais autores: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publishing
2024-04-01
|
| Colecção: | Therapeutic Advances in Neurological Disorders |
| Acesso em linha: | https://doi.org/10.1177/17562864241233041 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|